Neurology
Ulefnersen Data Presented at the Northeast ALS Consortium Annual Meeting
Scientific Publications & Presentations
Built on decades of scientific leadership, Ionis continues to advance the understanding of disease through groundbreaking research and innovation. Explore select publications across our therapeutic areas and technologies to better understand the science behind our medicines and pipeline.
Showing 13-24 out of 39 results
Other Medicines
Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis
Neurology
BIIB080 Data Presented at the Alzheimer's Association International Conference 2025
Neurology
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series
Other Medicines
Bepirovirsen Data Presented at EASL 2025
Other Medicines
Donidalorsen Data Presented at the American Academy of Allergy, Asthma, and Immunology/World Allergy Organization Joint Congress
Neurology
ION582 Data Presented at the Angelman Syndrome Foundation Family Conference and Research Symposium
Other Medicines
Efficacy and Safety of Donidalorsen for Hereditary Angioedema
Other Medicines
Data Presented at the American Society of Nephrology Kidney Week
Neurology
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease A Randomized Clinical
Neurology
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
Neurology
Eplontersen Data Presented at the American Academy of Neurology Annual Meeting